Cargando…
Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast
BACKGROUND: Scleroderma is traditionally managed with immunomodulatory agents such as methotrexate, mycophenolate mofetil and corticosteroids. There are anecdotal reports for, and theoretical reasons why, the anti-fibrotic agent tranilast may provide an additional treatment modality. OBJECTIVE: The...
Autor principal: | Noakes, Rowland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037270/ https://www.ncbi.nlm.nih.gov/pubmed/30013378 http://dx.doi.org/10.2147/CCID.S160923 |
Ejemplares similares
-
Uricosuric targets of tranilast
por: Mandal, Asim K., et al.
Publicado: (2017) -
Effects of Tranilast on the Urinary Excretion of Kynurenic and Quinolinic Acid Under Conditions of L Tryptophan Loading
por: Noakes, Rowland R.
Publicado: (2013) -
Pachydermodactyly Treated with Tranilast in a Young Girl
por: Higuchi, Chikahisa, et al.
Publicado: (2014) -
Tranilast enhances the effect of anticancer agents in osteosarcoma
por: Nakashima, Takayuki, et al.
Publicado: (2019) -
Tranilast Can be a Useful Addition to the Limited Anti-Epidermolysis Bullosa Weaponry
por: Parvizi, Mohammad Mahdi, et al.
Publicado: (2017)